Next report date
Report period
Q1 2024
EPS estimate
−0.05CAD
Revenue estimate
—
−0.180CAD
−15.89 MCAD
79.95 M
About SATELLOS BIOSCIENCE INC
Sector
CEO
Frank Gleeson
Headquarters
Toronto
Website
Employees (FY)
12
Founded
2018
FIGI
BBG000PZ2LF9
Satellos Bioscience, Inc. is a regenerative medicine company, which engages in developing novel therapeutics. It operates through a proprietary technology platform, MyoReGenX™ and Leveraging MyoReGenX™, which identify stem cell based regeneration deficits in muscle diseases and develop therapeutic solutions. The company was founded by Frank Gleeson and Michael Rudnicki in 2018 and is headquartered in Toronto, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of MSCL is 0.465 CAD — it has increased by 3.33% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSX exchange SATELLOS BIOSCIENCE INC stocks are traded under the ticker MSCL.
SATELLOS BIOSCIENCE INC is going to release the next earnings report on May 28, 2024. Keep track of upcoming events with our Earnings Calendar.
MSCL stock is 3.23% volatile and has beta coefficient of 0.37. Check out the list of the most volatile stocks — is SATELLOS BIOSCIENCE INC there?
MSCL earnings for the last quarter are −0.03 CAD per share, whereas the estimation was −0.03 CAD resulting in a −10.97% surprise. The estimated earnings for the next quarter are −0.01 CAD per share. See more details about SATELLOS BIOSCIENCE INC earnings.
Yes, you can track SATELLOS BIOSCIENCE INC financials in yearly and quarterly reports right on TradingView.
MSCL stock has fallen by 2.11% compared to the previous week, the month change is a 3.12% fall, over the last year SATELLOS BIOSCIENCE INC has showed a 33.57% decrease.
MSCL net income for the last quarter is −6.54 M CAD, while the quarter before that showed −3.57 M CAD of net income which accounts for −82.85% change. Track more SATELLOS BIOSCIENCE INC financial stats to get the full picture.
Today SATELLOS BIOSCIENCE INC has the market capitalization of 45.15 M, it has decreased by 5.88% over the last week.
No, MSCL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MSCL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SATELLOS BIOSCIENCE INC stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 30, 2024, the company has 12.00 employees. See our rating of the largest employees — is SATELLOS BIOSCIENCE INC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SATELLOS BIOSCIENCE INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SATELLOS BIOSCIENCE INC stock shows the sell signal. See more of SATELLOS BIOSCIENCE INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on SATELLOS BIOSCIENCE INC future price: according to them, MSCL price has a max estimate of 1.20 CAD and a min estimate of 1.00 CAD. Read a more detailed SATELLOS BIOSCIENCE INC forecast: see what analysts think of SATELLOS BIOSCIENCE INC and suggest that you do with its stocks.